Delloro, Baby Girl .
HRN: 27-07-34 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/08/2025
GENTAMICIN 40MG/ML, 2ML (AMP)
05/08/2025
05/14/2025
IV
17mg
Q24
NAMF (Hespes Zoster); Acute Bacterial Infection
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes